U.S. Capital Wealth Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
NA
SPIA
RA
WIA
FIB
U.S. Capital Wealth Advisors's REVS Position: Q1 2026 in Review
U.S. Capital Wealth Advisors increased its Columbia Research Enhanced Value ETF (REVS) stake by 100% in Q1 2026, buying an estimated $3.53M and bringing the position to 243,142 shares worth $6.96M. The position accounts for 0.18% of the portfolio, ranked #142.
U.S. Capital Wealth Advisors first reported a position in REVS in Q4 2025 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.
- U.S. Capital Wealth Advisors held 243,142 shares of Columbia Research Enhanced Value ETF worth $6.96M as of Q1 2026.
- U.S. Capital Wealth Advisors bought 121,316 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $3.53M.
- Columbia Research Enhanced Value ETF made up 0.18% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #142 holding.
- U.S. Capital Wealth Advisors first reported a position in Columbia Research Enhanced Value ETF in Q4 2025 and has held it in 2 quarters since.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.
Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.